LSE - Delayed Quote GBp

Oxford BioDynamics Plc (OBD.L)

Compare
0.9110
-0.0890
(-8.90%)
At close: January 10 at 4:26:20 PM GMT
Currency in GBP All numbers in thousands
Download
Breakdown
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
Total Revenue
510.0000
510.0000
154.0000
341.0000
456.0000
Cost of Revenue
244.0000
244.0000
38.0000
--
622.0000
Gross Profit
266.0000
266.0000
116.0000
341.0000
-166.0000
Operating Expense
10,434.0000
10,434.0000
8,717.0000
7,853.0000
4,785.0000
Operating Income
-10,168.0000
-10,168.0000
-8,601.0000
-7,512.0000
-4,951.0000
Net Non Operating Interest Income Expense
-141.0000
-141.0000
-184.0000
-83.0000
102.0000
Pretax Income
-11,411.0000
-11,411.0000
-7,567.0000
-7,629.0000
-4,946.0000
Tax Provision
-585.0000
-585.0000
-857.0000
-947.0000
-597.0000
Net Income Common Stockholders
-10,826.0000
-10,826.0000
-6,710.0000
-6,682.0000
-4,349.0000
Diluted NI Available to Com Stockholders
-10,826.0000
-10,826.0000
-6,710.0000
-6,682.0000
-4,349.0000
Basic EPS
-0.07
-0.07
-0.07
-0.07
-0.05
Diluted EPS
-0.07
-0.07
-0.07
-0.07
-0.05
Basic Average Shares
147,481.5660
147,481.5660
99,702.2570
92,559.7710
92,558.3170
Diluted Average Shares
147,481.5660
147,481.5660
99,702.2570
92,559.7710
92,558.3170
Total Operating Income as Reported
-10,168.0000
-10,168.0000
-8,601.0000
-7,512.0000
-4,951.0000
Rent Expense Supplemental
--
--
--
--
38.0000
Total Expenses
10,678.0000
10,678.0000
8,755.0000
7,853.0000
5,407.0000
Net Income from Continuing & Discontinued Operation
-10,826.0000
-10,826.0000
-6,710.0000
-6,682.0000
-4,349.0000
Normalized Income
-9,751.0847
-9,751.0847
-7,680.9859
-6,682.0000
-4,349.0000
Interest Income
72.0000
72.0000
11.0000
31.0000
121.0000
Interest Expense
213.0000
213.0000
195.0000
114.0000
19.0000
Net Interest Income
-141.0000
-141.0000
-184.0000
-83.0000
102.0000
EBIT
-11,198.0000
-11,198.0000
-7,372.0000
-7,515.0000
-4,927.0000
EBITDA
-9,841.0000
-9,841.0000
-6,159.0000
-6,427.0000
-4,460.0000
Reconciled Cost of Revenue
244.0000
244.0000
38.0000
--
622.0000
Reconciled Depreciation
1,357.0000
1,357.0000
1,213.0000
1,088.0000
467.0000
Net Income from Continuing Operation Net Minority Interest
-10,826.0000
-10,826.0000
-6,710.0000
-6,682.0000
-4,349.0000
Total Unusual Items Excluding Goodwill
-1,133.0000
-1,133.0000
1,095.0000
--
--
Total Unusual Items
-1,133.0000
-1,133.0000
1,095.0000
--
--
Normalized EBITDA
-8,708.0000
-8,708.0000
-7,254.0000
-6,427.0000
-4,460.0000
Tax Rate for Calcs
0.0001
0.0001
0.0001
0.0001
0.0001
Tax Effect of Unusual Items
-58.0847
-58.0847
124.0141
--
--
9/30/2020 - 12/6/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

1K0.BE IGM Biosciences Inc. R
6.00
0.00%
 
LSRM.SG CEL-SCI Corp
0.3992
+13.67%
 
LSRM.MU CEL-SCI Corp
0.3628
-0.38%
 
1K0.F IGM Biosciences, Inc.
1.9000
-68.33%
 
LSRM.F CEL-SCI Corporation
0.3478
-0.11%
 
1K0.MU IGM Biosciences Inc
4.8000
-21.31%
 
LSRM.BE CEL-SCI Corp
0.3470
+0.17%
 
LSRM.DU CEL-SCI Corp
0.3846
+9.57%
 
APTA.L Aptamer Group PLC
0.3300
0.00%
 
SLNCF Silence Therapeutics plc
1.6350
0.00%